Phebalosin is primarily studied for its potential antimicrobial properties, particularly against Gram-positive bacteria. It has shown activity in inhibiting bacterial growth by interfering with cell wall synthesis, making it a candidate for development in antibiotic therapies. Research is ongoing into its use as a lead compound for novel antibiotics, especially in addressing drug-resistant strains. Additionally, phebalosin has been explored for its role in biofilm disruption, which could enhance the efficacy of existing antimicrobial treatments. Furthermore, it has been investigated for inhibiting the growth of certain cancer cell types, suggesting potential applications in anti-tumor drug development. Its natural origin and specific mechanism of action support its investigation in pharmaceutical and biomedical applications. However, it remains in the research phase and requires further studies to confirm efficacy and safety for practical use.